New Target Identified for Scleroderma Therapy

Jun 14, 2010

(PhysOrg.com) -- Investigators at Northwestern University Feinberg School of Medicine have identified the molecule Egr-1 (early growth response factor 1) as a new therapy target for scleroderma, an autoimmune disease for which there currently is no cure.

Scleroderma, also known as systemic sclerosis, is a in which the body's immune system turns on itself. It causes progressive thickening and tightening (fibrosis) of the skin and also can lead to serious internal organ damage and, in some cases, death. Scleroderma affects an estimated 300,000 people in the United States, most frequently young to middle-aged women.

"The implications of our discovery are broad-ranging because fibrosis, or scarring, underlies not only scleroderma but also other more prevalent diseases such as , kidney fibrosis, , radiation-induced scars and many others," says John Varga, M.D., professor of medicine and of dermatology at Feinberg and a physician at Northwestern Memorial Hospital. "The role of Egr-1 in fibrosis that we have identified is likely to apply to all of these conditions."

The findings were spotlighted recently by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, along with similar research findings from the University of Pittsburgh School of Medicine. Both were published in the .

Pharmacological agents used to treat mellitus, inflammation and leukemia might block aberrant Egr-1 activity, Varga says, and could be useful as a novel treatment for scleroderma.

Varga directs the Northwestern Scleroderma Program, which is one of only a handful of centers in the nation that specialize in the disease. Since the disease affects multiple organs, optimal patient care requires the coordinated efforts of physicians from a wide variety of specialties to ensure comprehensive disease evaluation and management. Patients are also given the opportunity to participate in research studies, clinical trials and education programs.

For the latest findings, Varga led a research team that included Northwestern scientists from pathology, plastic surgery, immunology, and pulmonary and critical care medicine. In one study, the team reproduced scleroderma in mice to show that the levels of the protein Egr-1 become highly elevated in the scar tissue. In a second study, the team used mice where the gene for Egr-1 was genetically deleted to demonstrate protection from the development of skin and lung fibrosis, in contrast to the genetically normal mice. Because the understanding of scleroderma and fibrosis represents a major unmet medical need, fresh insights into the disease process might open the door for novel therapies.

"The Northwestern research team continues to make fundamental contributions to scleroderma by focusing on its underlying molecular and cellular basis," says Varga. "We believe that only by applying a careful mechanistic approach to dissect the role of cells, molecules and pathways in this disease can we make real progress. We are now closer to treatments that could control the disease."

Varga notes that interdisciplinary collaboration is necessary for discovery. "Scleroderma is an unusually complex disease that simultaneously attacks the vascular, immune and connective tissue systems and is affected by genetic factors," he says. "In order to understand this disease, it is essential to explore each of these processes."

Explore further: Girls in Colombian town struck by mystery illness

add to favorites email to friend print save as pdf

Related Stories

Study reveals new genetic link to scleroderma

Apr 29, 2010

An international research consortium including scientists from The University of Texas Health Science Center at Houston (UTHealth) has identified a new genetic link to the systemic form of scleroderma. Researchers believe ...

Causes found for stiff skin conditions

Mar 19, 2010

By studying the genetics of a rare inherited disorder called stiff skin syndrome, researchers at the Johns Hopkins University School of Medicine have learned more about scleroderma, a condition affecting about one in 5,000 ...

Researchers discover gene signatures for scleroderma

Jul 16, 2008

Distinct genetic profiles can discern different groups of patients with scleroderma, a vexing autoimmune disease in which the body turns against itself, Dartmouth Medical School researchers report. Their discovery of distinguishing ...

Tumor suppressor may attenuate fibrotic disease

Feb 17, 2009

New research reveals a critical cellular signaling pathway that is responsible for generating excess connective tissue in multiple organs, similar to what is seen in human patients with scleroderma. The study, published by ...

Study sheds light on deadly lung disease

Apr 14, 2008

Systemic sclerosis (SSc), also known as scleroderma, is characterized by the formation of fibrosis, or scar tissue, on internal organs as well as the skin. Beyond its disfiguring symptoms, SSc is associated with a high rate ...

Recommended for you

Girls in Colombian town struck by mystery illness

2 hours ago

A mystery illness has overwhelmed a small town in northern Colombia as scores of teenage girls have been hospitalized with symptoms that parents fear could be an adverse reaction to a popular vaccine against cervical cancer.

Oral contraceptive equal to antibiotics for acne care

9 hours ago

(HealthDay)—At six months, oral contraceptive pills (OCPs) are comparable to systemic antibiotics for acne management, according to a review published in the September issue of the Journal of the American Ac ...

Photodynamic therapy vs. cryotherapy for actinic keratoses

10 hours ago

Photodynamic therapy (PDT, which uses topical agents and light to kill tissue) appears to better clear actinic keratoses (AKs, a common skin lesion caused by sun damage) at three months after treatment than cryotherapy (which ...

US official warns Ebola outbreak will get worse

12 hours ago

A third top doctor has died from Ebola in Sierra Leone, a government official said Wednesday, as a leading American health official warned that the outbreak sweeping West Africa would get worse before it ...

User comments : 0